|
1
|
Ng M, Fleming T, Robinson M, Thomson B,
Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF,
et al: Global, regional, and national prevalence of overweight and
obesity in children and adults during 1980–2013: A systematic
analysis for the global burden of disease study 2013. Lancet.
384:766–781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman JM: Obesity: Causes and control
of excess body fat. Nature. 459:340–342. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Renehan AG, Tyson M, Egger M, Heller RF
and Zwahlen M: Body-mass index and incidence of cancer: A
systematic review and meta-analysis of prospective observational
studies. Lancet. 371:569–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bjorge T, Tretli S and Engeland A:
Relation of height and body mass index to renal cell carcinoma in
two million Norwegian men and women. Am J Epidemiol. 160:1168–1176.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pischon T, Lahmann PH, Boeing H,
Tjønneland A, Halkjaer J, Overvad K, Klipstein-Grobusch K,
Linseisen J, Becker N, Trichopoulou A, et al: Body size and risk of
renal cell carcinoma in the European prospective investigation into
cancer and nutrition (EPIC). Int J Cancer. 118:728–738. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bardou M, Barkun AN and Martel M: Obesity
and colorectal cancer. Gut. 62:933–947. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cantarutti A, Bonn SE, Adami HO, Grönberg
H, Bellocco R and Bälter K: Body mass index and mortality in men
with prostate cancer. Prostate. 75:1129–1136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schips L, Lipsky K, Zigeuner R, Gidaro S,
Salfellner M, Rehak P, Pummer K and Hubmer G: Does overweight
impact on the prognosis of patients with renal cell carcinoma? A
single center experience of 683 patients. J Surg Oncol. 88:57–62.
2014. View Article : Google Scholar
|
|
9
|
Parker AS, Lohse CM, Cheville JC, Thiel
DD, Leibovich BC and Blute ML: Greater body mass index is
associated with better pathologic features and improved outcome
among patients treated surgically for clear cell renal cell
carcinoma. Urology. 68:741–746. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haferkamp A, Pritsch M, Bedke J, Wagener
N, Pfitzenmaier J, Buse S and Hohenfellner M: The influence of body
mass index on the long-term survival of patients with renal cell
carcinoma after tumour nephrectomy. BJU Int. 101:1243–1246. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Awakura Y, Nakamura E, Ito N, Yamasaki T,
Kamba T, Kamoto T and Ogawa O: Influence of body mass index on
prognosis of Japanese patients with renal cell carcinoma. Urology.
70:50–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi Y, Park B, Jeong BC, Seo SI, Jeon SS,
Choi HY, Adami HO, Lee JE and Lee HM: Body mass index and survival
in patients with renal cell carcinoma: A clinical-based cohort and
meta-analysis. Int J Cancer. 132:625–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hakimi AA, Furberg H, Zabor EC, Jacobsen
A, Schultz N, Ciriello G, Mikklineni N, Fiegoli B, Kim PH, Voss MH,
et al: An epidemiologic and genomic investigation into the obesity
paradox in renal cell carcinoma. J Natl Cancer Inst. 105:1862–1870.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HL, Belldegrun AS, Freitas DG, Bui MH,
Han KR, Dorey FJ and Figlin RA: Paraneoplastic signs and symptoms
of renal cell carcinoma: Implications for prognosis. J Urol.
170:1742–1746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim HL, Han KR, Zisman A, Figlin RA and
Belldegrun AS: Cachexia-like symptoms predict a worse prognosis in
localized t1 renal cell carcinoma. J Urol. 171:1810–1813. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wolf I, Sadetzki S, Kanety H, Kundel Y,
Pariente C, Epstein N, Oberman B, Catane R, Kaufman B and Shimon I:
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and
colon cancer patients. Cancer. 106:966–973. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the eastern cooperative oncology group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
WHO Expert Consultation, . Appropriate
body-mass index for Asian populations and its implications for
policy and intervention strategies. Lancet. 363:157–163. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Horiguchi A, Oya M, Marumo K and Murai M:
STAT3, but not ERKs, mediates the IL-6-induced proliferation of
renal cancer cells, ACHN and 769P. Kidney Int. 61:926–938. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ding GX, Feng CC, Song NH, Fang ZJ, Xia
GW, Jiang HW, Hua LX and Ding Q: Paraneoplastic symptoms: Cachexia,
polycythemia, and hypercalcemia are, respectively, related to
vascular endothelial growth factor (VEGF) expression in renal clear
cell carcinoma. Urol Oncol. 31:1820–1825. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oya M: Renal cell carcinoma: Biological
features and rationale for molecular-targeted therapy. Keio J Med.
58:1–11. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Park YH, Lee JK, Kim KM, Kook HR, Lee H,
Kim KB, Lee S, Byun SS and Lee SE: Visceral obesity in predicting
oncologic outcomes of localized renal cell carcinoma. J Urol.
192:1043–1049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fox CS, Massaro JM, Hoffmann U, Pou KM,
Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB,
Cupples LA, et al: Abdominal visceral and subcutaneous adipose
tissue compartments: Association with metabolic risk factors in the
framingham heart study. Circulation. 116:39–48. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doyle SL, Donohoe CL, Lysaght J and
Reynolds JV: Visceral obesity, metabolic syndrome, insulin
resistance and cancer. Proc Nutr Soc. 71:pp. 181–189. 2012;
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ibrahim MM: Subcutaneous and visceral
adipose tissue: Structural and functional differences. Obes Rev.
11:11–18. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schapira DV, Clark RA, Wolff PA, Jarrett
AR, Kumar NB and Aziz NM: Visceral obesity and breast cancer risk.
Cancer. 74:632–639. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Oh TH, Byeon JS, Myung SJ, Yang SK, Choi
KS, Chung JW, Kim B, Lee D, Byun JH, Jang SJ and Kim JH: Visceral
obesity as a risk factor for colorectal neoplasm. J Gastroenterol
Hepatol. 23:411–417. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dahlman I, Mejhert N, Linder K, Agustsson
T, Mutch DM, Kulyte A, Isaksson B, Permert J, Petrovic N,
Nedergaard J, et al: Adipose tissue pathways involved in weight
loss of cancer cachexia. Br J Cancer. 102:1541–1548. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fouladiun M, Körner U, Bosaeus I, Daneryd
P, Hyltander A and Lundholm KG: Body composition and time course
changes in regional distribution of fat and lean tissue in
unselected cancer patients on palliative care-correlations with
food intake, metabolism, exercise capacity, and hormones. Cancer.
103:2189–2198. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ali SM and Lindström M: Socioeconomic,
psychosocial, behavioural, and psychological determinants of BMI
among young women: Differing patterns for underweight and
overweight/obesity. Eur J Public Health. 16:325–331. 2006.
View Article : Google Scholar : PubMed/NCBI
|
